jueves, 15 de febrero de 2018

NIAID Email Alert: Type 1 Diabetes Tolerance R01

NIAID Logo

Funding Opportunity

  • RFA-DK-17-020, Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01, Clinical Trial Not Allowed)

No hay comentarios: